Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rupatadine 20 mg crossover study in mastocytosis symptoms
2010-021001-21Phase 2Completed
- Sponsor
- Allergie-Centrum Charité
- Start
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of rupatadine in mastocytosis, cutaneous mastocytosis (CM) and systemic mastocytosis (SM) (2 arms), sponsored by Allergie-Centrum Charité. Primary endpoint: Primary efficacy endpoint. Started Jun 2010; status: completed.
02
Drugs
rupatadine
03
Conditions
mastocytosiscutaneous mastocytosis (CM)systemic mastocytosis (SM)
Beyond the preview
Go deeper on 2010-021001-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021001-21.